The information on this site is intended to supplement and enhance, not replace, the advice of a physician who is familiar with your medical history. Decisions about your health should always be made ONLY after detailed conversation with your doctor.
Generic drug name:
glargine insulin
(GLARE jeen)
Brand name(s):
BASAGLAR,
LANTUS,
TOUJEO
GENERIC:
not available
FAMILY:
Insulins
Find the drug label by
searching at DailyMed.
Generic drug name:
human insulin
Brand name(s):
HUMULIN,
HUMULIN 70/30,
ILETIN,
INSULATARD,
LEVEMIR,
MIXTARD,
NOVOLIN,
VELOSULIN
GENERIC:
not available
FAMILY:
Insulins
Find the drug label by
searching at DailyMed.
Generic drug name:
lispro insulin
(LYE sproe)
Brand name(s):
HUMALOG,
HUMAPEN MEMOIR
GENERIC:
not available
FAMILY:
Insulins
Find the drug label by
searching at DailyMed.
Pregnancy and Breast-feeding Warnings [top]
Pregnancy Warning
No information is available on the effects of insulin on the developing fetus from either human or animal studies. Insulin does not cross the placenta, and it is thought that the benefits would outweigh any risk to the fetus. Tell your doctor if you are pregnant or thinking of becoming pregnant.
Breast-feeding Warning
It is likely that this drug, like many others, is excreted in human milk. Because of the potential for adverse effects of insulin on nursing infants, you should consult your physician as to the safety of breast-feeding.
Safety Warnings For This Drug [top]
Glargine insulin must not be diluted or mixed with any other insulin or solution.
Facts About This Drug [top]
Insulin works by regulating the amount of sugar (glucose) in the blood and the speed at which sugar moves into cells. In diabetics, instead of moving into the cells, the sugar accumulates in the blood, resulting in very high blood sugar levels. Diet affects the cells’ need for insulin and the insulin’s ability to lower blood sugar when necessary. Therefore, for insulin to work, a prescribed diet must be followed. Insulin is not a replacement for such a diet.
Too much insulin may cause low...
Insulin works by regulating the amount of sugar (glucose) in the blood and the speed at which sugar moves into cells. In diabetics, instead of moving into the cells, the sugar accumulates in the blood, resulting in very high blood sugar levels. Diet affects the cells’ need for insulin and the insulin’s ability to lower blood sugar when necessary. Therefore, for insulin to work, a prescribed diet must be followed. Insulin is not a replacement for such a diet.
Too much insulin may cause low blood sugar (hypoglycemia). This happens most often in people who are over 60, especially if they have reduced kidney function, and also occurs frequently in young diabetics with type 1, so-called juvenile-onset, diabetes. Risk of suffering from hypoglycemia increase with the following behavior: skipping or delaying meals, exercising more than usual or drinking significant amounts of alcohol.
The first insulin came from animal sources, the pancreases of cattle or swine. Today the majority of insulin used in the U.S. is produced in bacteria using DNA biotechnology. Animal-source insulin differs slightly in chemical structure from that of human insulin. HUMULIN is one brand of human insulin produced using DNA technology and chemically identical to human insulin. Glargine insulin (LANTUS) and lispro insulin (HUMALOG, HUMAPEN MEMOIR), also produced by DNA technology, are modifications of human insulin and are referred to as insulin analogs. Clinical trials show that there is no difference in diabetes control according to the type of insulin used, in either type 1 or type 2 diabetes.
Properly designed clinical trials have shown that strict control of blood sugar in patients with type 1 diabetes using insulin reduces the risk of the serious complications of diabetes.[1],[2]
Although there is an emphasis on stricter glucose control than before, there are still concerns about the hazards of low blood sugar (hypoglycemia) if control is too strict.[3],[4],[5],[6] Overly strict glucose control also resulted in more auto accidents for diabetics, due to sudden episodes of hypoglycemia.[3],[4] Studies conflict on whether severe and frequent episodes of low blood sugar hasten decline in intellectual ability.[7],[8],[5] Prior objections to frequent testing centered on the concern over making people too preoccupied with being ill. Diabetic therapy must be individualized.
Glargine insulin
Glargine insulin is a long-acting insulin analog produced using DNA technology and approved by the Food and Drug Administration (FDA) in April 2000.
In one clinical trial submitted to the FDA in support of glargine insulin’s approval, one measure of eye damage from diabetes (retinopathy) in patients with type 2 diabetes showed a higher incidence with glargine insulin than with NPH insulin (isophane insulin, an older form of long-acting insulin). The difference was 7.5 percent versus 2.5 percent respectively.[9]
The FDA medical officer who reviewed glargine insulin prior to its marketing approval recommended that the professional product labeling for this product say that “no claim of superiority to NPH insulin should be allowed.”[10]
Regulatory actions surrounding glargine insulin
2009: The FDA issued a safety alert based on data from four published studies concerning the use of glargine insulin and a possible risk for cancer in patients using this medication. The FDA is continuing to evaluate safety data to determine and assess if there is a potential link between glargine insulin and this risk.[11]
Public Citizen has reviewed the studies and has found that there are inconsistencies in the data. Based on these inconsistencies, it is not clear that a definite link between glargine insulin and cancer can be concluded.[12]
2011: In January, the FDA issued safety information stating that it has reviewed the studies on glargine insulin and has found that the evidence available does not show that the reported risk of cancer is linked to glargine insulin use. The FDA will continue to review information.[13]
Human insulin
Human insulin (HUMULIN, HUMULIN 70/30, INSULATARD, MIXTARD, NOVOLIN, VELOSULIN) produced by DNA technology is formulated in a number of different forms to alter both its onset and duration of effect. These forms may also be mixed, under the instruction of a physician or diabetes educator, to better individualize blood sugar control.
Lispro insulin
Lispro insulin has a more rapid onset of action and shorter duration than human insulin. Some cases of resistance to human insulin have been successfully treated with lispro insulin.[14] According to a meta-analysis of trials comparing lispro insulin with human insulin, lispro insulin does not alter the risk of hypoglycemia.[15] In practice, lispro insulin can be administered just before meals, which is an advantage over human insulin, which has to be administered 30 to 45 minutes before meals.
Before You Use This Drug [top]
Tell your doctor if you have or have had:
Tell your doctor about any other drugs you take, including aspirin, herbs, vitamins, and other nonprescription products.
When You Use This Drug [top]
How to Use This Drug [top]
Interactions with Other Drugs [top]
The following drugs, biologics (e.g., vaccines, therapeutic antibodies), or foods are listed in Evaluations of Drug Interactions 2003 as causing “highly clinically significant” or “clinically significant” interactions when used together with any of the drugs in this section. In some sections with multiple drugs, the interaction may have been reported for one but not all drugs in this section, but we include the interaction because the drugs in this section are similar to one another. We have also included potentially serious interactions listed in the drug’s FDA-approved professional package insert or in published medical journal articles. There may be other drugs, especially those in the families of drugs listed below, that also will react with this drug to cause severe adverse effects. Make sure to tell your doctor and pharmacist the drugs you are taking and tell them if you are taking any of these interacting drugs:
alcohol, ARMOUR THYROID, ATROMID-S, clofibrate, fenugreek, guanethidine, INDERAL, INDERAL LA, ISMELIN, LEVOTHROID, levothyroxine, NARDIL, oxytetracycline, phenelzine, propranolol, SYNTHROID, TERRAMYCIN, thyroid, timolol, TIMOPTIC.
In addition, the 2003 edition of the USP’s (United States Pharmacopoeia’s) Drug Information for the Health Care Professional lists these drugs as having interaction of major significance: the family of drugs known as beta-blockers, which includes propranolol (INDERAL, INDERAL LA).
Corticosteroids, which include drugs such as prednisone (DELTASONE, METICORTEN).
Adverse Effects [top]
Any insulin may cause allergies in a few individuals.[21],[22] Skin cleansers and preservatives in the insulin also can cause local allergic reactions.
Call your doctor immediately if you experience:
Low blood sugar
High blood sugar
Periodic Tests[top]
Ask your doctor which of these tests should be done periodically while you are taking this drug and how often they should be done:
last reviewed June 30, 2024